Total Payments
$5,118
2024 Payments
$1,182
Companies
35
Transactions
264
Medicare Patients
2,076
Medicare Billing
$290,482
Payment Breakdown by Category
Food & Beverage$4,805 (93.9%)
Travel$232.76 (4.5%)
Education$80.00 (1.6%)
Gifts$0.01 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,805 | 257 | 93.9% |
| Travel and Lodging | $232.76 | 3 | 4.5% |
| Education | $80.00 | 3 | 1.6% |
| Gift | $0.01 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,084 | 64 | $0 (2024) |
| Medtronic, Inc. | $645.32 | 13 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $489.88 | 26 | $0 (2024) |
| GRT US Holding, Inc. | $431.47 | 15 | $0 (2022) |
| Lundbeck LLC | $289.75 | 9 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $258.19 | 14 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $221.84 | 16 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $139.47 | 12 | $0 (2021) |
| Forte Bio-Pharma LLC | $138.00 | 10 | $0 (2023) |
| Amgen Inc. | $136.40 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,182 | 43 | Medtronic, Inc. ($631.04) |
| 2023 | $1,076 | 57 | ABBVIE INC. ($396.00) |
| 2022 | $1,528 | 79 | GRT US Holding, Inc. ($354.01) |
| 2021 | $1,332 | 85 | AbbVie Inc. ($225.25) |
All Payment Transactions
264 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Neuromodulation | ||||||
| 11/13/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/07/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: OUD | ||||||
| 11/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.18 | General |
| Category: Opioid Analgesic | ||||||
| 10/30/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/02/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/19/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 09/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: Opioid Analgesic | ||||||
| 08/13/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Analgesic | ||||||
| 08/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: OUD | ||||||
| 06/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Gastroenterology | ||||||
| 06/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/18/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Not Applicable | ||||||
| 06/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: General - Pain Management_NMD | ||||||
| 06/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Central Nervous System | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Orthopedic | ||||||
| 05/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 442 | 1,087 | $528,196 | $60,496 |
| 2022 | 6 | 499 | 1,235 | $496,804 | $72,107 |
| 2021 | 5 | 591 | 1,428 | $572,996 | $85,660 |
| 2020 | 5 | 544 | 1,309 | $522,757 | $72,219 |
Total Patients
2,076
Total Services
5,059
Medicare Billing
$290,482
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 616 | $295,821 | $30,423 | 10.3% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 102 | 140 | $89,985 | $15,685 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 162 | $112,969 | $11,047 | 9.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 100 | 133 | $12,975 | $1,633 | 12.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $12,363 | $1,363 | 11.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 15 | 15 | $4,083 | $343.50 | 8.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 507 | $283,920 | $33,303 | 11.7% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 98 | 156 | $44,627 | $17,645 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 365 | $135,902 | $17,099 | 12.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 109 | 172 | $16,193 | $2,141 | 13.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $13,180 | $1,520 | 11.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 11 | $2,981 | $399.25 | 13.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 202 | 734 | $410,630 | $53,185 | 13.0% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 119 | 141 | $40,336 | $15,958 | 39.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 231 | $86,170 | $12,012 | 13.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 155 | 310 | $29,140 | $3,807 | 13.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $6,720 | $699.27 | 10.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 157 | 488 | $272,822 | $32,926 | 12.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 152 | 481 | $185,660 | $21,364 | 11.5% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 107 | 127 | $36,331 | $14,364 | 39.5% |
| 80305 | Testing for presence of drug | Office | 2020 | 111 | 196 | $18,424 | $2,450 | 13.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 17 | 17 | $9,520 | $1,116 | 11.7% |
About Shelley Vanhoozer, APRN
Shelley Vanhoozer, APRN is a Nurse Practitioner healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1053546150.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shelley Vanhoozer, APRN has received a total of $5,118 in payments from pharmaceutical and medical device companies, with $1,182 received in 2024. These payments were reported across 264 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,805).
As a Medicare-enrolled provider, Vanhoozer has provided services to 2,076 Medicare beneficiaries, totaling 5,059 services with total Medicare billing of $290,482. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Adult Health
- Location Omaha, NE
- Active Since 05/19/2009
- Last Updated 08/23/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1053546150
Products in Payments
- UBRELVY (Drug) $537.75
- QULIPTA (Drug) $534.19
- SYNCHROMEDII (Device) $432.55
- Qutenza (Drug) $431.47
- ZTLido (Drug) $396.59
- VYEPTI (Biological) $289.75
- NURTEC ODT (Drug) $225.12
- RELISTOR (Drug) $221.84
- INTELLIS ADAPTIVESTIM (Device) $198.30
- XTAMPZA (Drug) $162.13
- Aimovig (Biological) $136.40
- NALOCET (Drug) $118.61
- BELBUCA (Drug) $114.97
- AJOVY (Biological) $96.23
- EMGALITY (Drug) $88.96
- Horizant (Drug) $73.49
- Trudhesa (Drug) $73.27
- GRALISE (Drug) $71.52
- PROCLAIM (Device) $59.84
- HORIZANT (Drug) $52.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Omaha
Ms. Kristen Hammes, Aprn, APRN
Nurse Practitioner — Payments: $816,075
Nurse Practitioner $816,075
Kari Cunningham, Aprn, APRN
Nurse Practitioner — Payments: $53,327
Nurse Practitioner $53,327
Laura Donovan, Aprn, APRN
Nurse Practitioner — Payments: $40,286
Nurse Practitioner $40,286
Kathleen Healey, Aprn, APRN
Nurse Practitioner — Payments: $35,367
Nurse Practitioner $35,367
Ms. Katie Ruch, Aprn, APRN
Nurse Practitioner — Payments: $25,880
Nurse Practitioner $25,880
Leslie Dvorak, Aprn, APRN
Nurse Practitioner — Payments: $25,732
Nurse Practitioner $25,732